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Abstract
Background: Human tumors differ from normal tissues in their capacity to present Hsp70, the major stress-inducible
member of the HSP70 family, on their plasma membrane. Membrane Hsp70 has been found to serve as a prognostic
indicator of overall patient survival in leukemia, lower rectal and non small cell lung carcinomas. Why tumors, but not
normal cells, present Hsp70 on their cell surface and the impact of membrane Hsp70 on cancer progression remains to be
elucidated.
Methodology/Principal Findings: Although Hsp70 has been reported to be associated with cholesterol rich microdomains
(CRMs), the partner in the plasma membrane with which Hsp70 interacts has yet to be identified. Herein, global lipid
profiling demonstrates that Hsp70 membrane-positive tumors differ from their membrane-negative counterparts by
containing significantly higher amounts of globotriaoslyceramide (Gb3), but not of other lipids such as lactosylceramide
(LacCer), dodecasaccharideceramide (DoCer), galactosylceramide (GalCer), ceramide (Cer), or the ganglioside GM1. Apart
from germinal center B cells, normal tissues are Gb3 membrane-negative. Co-localization of Hsp70 and Gb3 was selectively
determined in Gb3 membrane-positive tumor cells, and these cells were also shown to bind soluble Hsp70-FITC protein
from outside in a concentration-dependent manner. Given that the latter interaction can be blocked by a Gb3-specific
antibody, and that the depletion of globotriaosides from tumors reduces the amount of membrane-bound Hsp70, we
propose that Gb3 is a binding partner for Hsp70. The in vitro finding that Hsp70 predominantly binds to artificial liposomes
containing Gb3 (PC/SM/Chol/Gb3, 17/45/33/5) confirms that Gb3 is an interaction partner for Hsp70.
Conclusions/Significance: These data indicate that the presence of Gb3 enables anchorage of Hsp70 in the plasma
membrane of tumors and thus they might explain tumor-specific membrane localization of Hsp70.
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Introduction
Heat shock proteins (HSPs) with a molecular weight of
approximately 70 kDa are located in most cellular compartments,
in which they support the folding of nascent polypeptides, prevent
protein aggregation and assist the transport of other proteins
across membranes [1,2]. Using flow cytometry of viable tumor
cells and selective cell surface iodination, we have previously
demonstrated a tumor-specific, plasma membrane localization of
Hsp70, the major stress-inducible member of the HSP70 family
[3]. These findings concur with other studies that have used global
profiling of membrane-bound proteins to show that there is an
abundance of molecular chaperones, including Hsp70, in the
plasma membrane of tumor cell lines [4]. Extracellular and
membrane-bound Hsp70 play pivotal roles in the innate immune
system [5] and we have shown that the latter acts as a target
structure for natural killer (NK) cells. Using autologous tumor
sublines which differentially express membrane Hsp70, as
generated by antibody-based cell sorting, we have demonstrated
that Hsp70 membrane-positive tumor cells are significantly more
susceptible to NK cell-mediated killing than their counterparts
which express low levels of membrane-bound Hsp70 [3,5].
Although the immunological relevance of membrane-bound
Hsp70 is apparent, little is known about the binding partners that
enable membrane anchorage of Hsp70 in viable tumor cells.
Herein we report that approximately 15 to 20% of the total
cellular Hsp70 content of tumor cells is present on the cell surface.
High-salt conditions and low/high pH did not alter Hsp70
membrane expression (unpublished observation), a finding which
indicates that it is unlikely that Hsp70 is bound to a proteinous cell
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surface component. These data suggest that, in contrast to antigen
presenting cells to which HSPs bind via cell surface receptors [6],
in tumor cells, Hsp70 might be associated with fatty acids within
the plasma membrane, as was suggested by Hightower and
Guidon in 1989 [7]. More recently, evidence that stress proteins,
including Hsp70, are present in glycosphingolipid and cholesterol-
rich microdomains (CRMs) of tumor cells has accumulated [8–
10]. In line with these findings, we show that the depletion of
cholesterol results in loss of membrane-bound Hsp70 in tumor
cells. Furthermore, a comparative analysis of the lipid molecular
species in the plasma membrane of Hsp70 membrane-positive and
-negative tumor cells revealed that the content of globoyltriao-
sylceramide (Gb3), a component of cholesterol-rich microdomains,
but not that of other ceramide-derived glycosphingolipids, was
significantly higher in Hsp70 membrane-positive tumor sublines.
The globotriaoside Gb3 is a marker for the germinal stage B cell
development and thus is highly overexpressed in Burkitt’s
lymphoma cells such as Daudi cells [11–13]. Functionally, Gb3
is a receptor for the AB5-toxin Shiga toxin and related toxins such
as Verotoxin [14,15]. Co-staining of Gb3 and Hsp70 in the
plasma membrane of Hsp70-positive tumor cells and a concen-
tration-dependent binding of Hsp70 to Gb3-positive tumors is
consistent with this finding. The selective binding of Hsp70 to
artificial Gb3-containing lipid vesicles further supports our
hypothesis that Gb3 is a prerequisite for the integration of
Hsp70 in the plasma membrane in tumor cells.
Results
Comparative Analysis of the Hsp70 Content in the
Cytosol and on the Plasma Membrane of Tumor Cells
The human colon (CX2) and human pancreas (Colo357)
carcinoma cell lines were separated into sublines exhibiting a
stably high (CX+, Colo+) or low (CX2, Colo2) membrane Hsp70
expression by Hsp70 monoclonal antibody (mAb)-based cell
sorting, as has been described previously [16,17]. Under
physiological conditions, 8768% of CX+ and 7365% of Colo+
tumor sublines were Hsp70 membrane-positive, whereas only
2366% of CX2 and 3465% of Colo2 carcinoma sublines were
Hsp70 membrane-positive (Table 1).
We have previously shown that transfection of the human cervix
carcinoma cell line HeLa with Bag-4 increases cell surface
expression of Hsp70 (HeLa+, 7868% vs 3664% on neo-
transfected HeLa cells, HeLa-) [18]. Bag-4/neo transfection was
therefore used to generate another tumor cell model in which a
differential membrane Hsp70 expression was apparent (Table 1).
The Burkitt’s lymphoma cell line Daudi displays a strong Hsp70
staining on the plasma membrane of all cells (9964%).
To exclude non-specific staining, membrane expression was
only measured in viable (7-AAD negative) cells which had intact
plasma membranes. In addition, phosphatidylserine (PS), an early
marker for apoptosis, was not present on the outer leaflet of the
plasma membrane, since none of the tumor cell lines bound
fluorescently labelled Annexin-V in the presence of physiological
concentrations of Ca2+ (data not shown).
The amount of membrane-bound Hsp70 was determined by
Western blot analysis of biotinylated plasma membrane proteins
(purity .97%). For this, surface-bound proteins on intact tumor
cells were selectively biotinylated and labeled proteins were
isolated using avidin agarose beads. Bound proteins and whole
cell membranes from the same tumor subline were subjected to
SDS-PAGE, blotted on nitrocellulose and stained with an Hsp70-
specific mAb (cmHsp70.1, multimmune GmbH). As shown in
Figure 1, the cytoplasmic Hsp70 content in CX+/CX2 and
Colo+/Colo2 sublines was similar under physiological conditions.
We have previously reported that the Hsp70 content is similarly
elevated in both tumor cell systems following stress [18]. A
comparison of cytosolic and membrane-bound Hsp70 content
revealed that approximately 20% and 15% of the total Hsp70 is
present in the plasma membrane of CX+ and Colo+ tumor cells,
Table 1. Flow cytometric analysis of viable, 7-AAD- and
Annexin-V-negative CX+/CX2, Colo+/Colo2 and HeLa+/
HeLa2 (HeLa Bag-4/HeLa neo) carcinoma sublines and Daudi
Burkitt’s lymphoma cells.
Proportion of Hsp70 membrane-positive cells (%6SE)a
CX+ CX2 Colo+ Colo2 HeLa+ HeLa2 Daudi
Hsp70 8768 2366 7365 3465 7868 3664 9964
aData are mean percentages of Hsp70 (cmHsp70.1) plasma membrane positive
cells6SE from 3 independent experiments.
doi:10.1371/journal.pone.0001925.t001
Figure 1. Quantification of cytosolic and plasma membrane-
bound Hsp70 in CX+/CX2 and Colo+/Colo2 carcinoma sub-
lines. Western blot analysis of biotinylated whole cell lysates
(cytoplasm, upper graph), and plasma membranes (lower graph) of
CX+/CX2 and Colo+/Colo2 tumor sublines. A corresponding Western
blot was stained with the Hsp70 specific mAb cmHsp70.1. The figure
shows a representative blot from three independent experiments. The
Hsp70 surface phenotypes of the tumor sublines, as determined by flow
cytometric analysis, are summarized in Table 1.
doi:10.1371/journal.pone.0001925.g001
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respectively. In contrast, less than 3% of total Hsp70 was found in
the plasma membranes of Hsp70 low-expressing CX2 and Colo2
tumor sublines.
Hsp70 is associated with cholesterol rich microdomains
(CRMs)
The amount of membrane Hsp70 is not affected by high salt or
by alkali/acid treatment (unpublished observation). Thus, a
protein-mediated interaction of Hsp70 with a protein compound
of the cell surface appears to be unlikely. Therefore, it was
hypothesized that Hsp70 might be directly associated with lipid
components of the plasma membrane. However, a comparative
lipid profiling of whole cell membranes and purified plasma
membranes of corresponding tumor sublines with differential
Hsp70 membrane expression using electrospray tandem mass
spectrometry revealed no significant differences in phosphatidyl-
choline (PC), sphingomyelin (SPM), dihydrosphingomyelin
(DiSPM), phosphatidylethanolamine (PE), phosphatidylserine
(PS), ceramide (Cer), and glucosylceramide (GluCer) composition
(Table 2). Although the amount of the sphingolipids sphingosine
(SPH) and sphinganine (SPA) was 100-fold lower than other lipid
components, levels in Hsp70 membrane-positive and –negative
tumor subtypes were similar (data not shown).
Given work from others which suggests that, apart form the
cytosolic localization, Hsp70 can be located in CRMs [6–9], the
potential association of Hsp70 with CRMs was investigated using
CX+ and CX2 colon carcinoma sublines that had been treated
with reagents which dissociate cholesterol from the plasma
membrane. Methyl-beta cyclodextrin (MbCD) concentrations of
up to 10 mM were determined to be sublethal using a standard
Table 2. Lipid composition and lipid ratio of whole cell
membranes and purified plasma membranes of CX+/CX2,
Colo+/Colo2, and HeLa+/HeLa2 tumor sublines.
Lipids PC SPM DihSPM PE PS Cer GluCer
Whole cell membranes
CX+ 38.868.1a 2.860.5 0.760.2 6.260.4 6.862.7 0.660.4 0.160.1
CX2 37.066.7 3.960.3 0.560.2 5.360.6 8.564.8 0.660.5 0.160.1
Ratio 1.04 0.72 1.4 1.17 0.80 1.0 1.0
Colo+ 38.968.7 5.761.2 0.760.3 6.961.0 8.865.1 0.560.3 0.160.1
Colo2 36.767.4 5.460.5 0.860.4 6.760.6 8.564.1 0.560.3 0.160.1
Ratio 1.06 1.06 0.88 1.03 1.04 1.0 1.0
HeLa+ 31.264.7 7.260.3 0.660.1 9.760.4 9.363.9 0.460.4 0.160.1
HeLa2 30.365.6 7.660.5 0.560.2 10.761.1 8.463.2 0.560.5 0.160.1
Ratio 1.03 0.95 1.20 0.91 1.11 0.80 1.0
Lipids PC SPM DihSPM PE PS Cer GluCer
Plasma membranes
CX+ 44.160.3 3.360.2 0.760.0 6.160.4 4.260.2 0.360.1 0.160.0
CX2 41.163.0 3.960.4 0.860.1 5.660.7 4.260.2 0.360.0 0.160.0
Ratio 1.07 0.85 0.88 1.09 1.0 1.0 1.0
Colo+ 41.860.1 5.165.3 1.060.0 5.960.0 5.060.3 0.360.0 0.060.0
Colo2 42.060.2 5.360.1 0.860.0 6.160.1 4.860.4 0.360.0 0.060.0
Ratio 0.99 0.96 1.25 0.97 1.04 1.0
HeLa+ 35.961.3 7.560.0 0.760.0 9.660.5 5.460.0 0.160.0 0.060.0
HeLa2 35.561.2 7.560.7 0.760.2 10.760.7 5.560.1 0.160.0 0.060.0
Ratio 1.01 1.01 1.0 0.90 0.98 1.0
Data are displayed as the lipid content and ratio in Hsp70 membrane-positive
vs membrane-negative carcinoma sublines. The calculation for total lipid
content is based on the sum of all analyzed lipid classes in nM/mg protein. The
lipid classes are calculated from the respective mol % value of all analyzed
lipids.
aData are means6SE of 3 to 4 independent experiments. PC,
phosphatidylcholine; SPM, sphingomyelin; DiSPM, DihydroSPM; PE,
phosphatidylethanolamine; PS, phosphatidylserine; Cer, ceramide; GluCer,
glucosylCer
doi:10.1371/journal.pone.0001925.t002
Figure 2. Hsp70 is associated with detergent resistant micro-
domains (DRMs). (A) Definition of the sublethal concentration of the
raft disrupting agent methyl-beta cyclodextrin (MbCD). Following
incubation of CX+ and CX2 tumor sublines with 1 and 10 mM MbCD
for 1 h, cells were washed and viability was determined by trypan blue
staining after a 12 h recovery period. (B) The images show filipin III
binding to untreated (ctrl, left graphs) and to CX+/CX2 tumor sublines
treated with the sublethal concentration of 1 mM MbCD (right graphs)
for 1 h. (C) Cell surface density of Hsp70 in untreated (ctrl) and MbCD
(1 mM, 10 mM) treated CX+ cells. Viability was 97.760.4 for control and
9560.7 for MbCD treated cells. The data represent mean fluorescence
intensity (mfi) values of three independent flow cytometric analyses.
*Indicates values that are significantly different from control (P = 0.006).
doi:10.1371/journal.pone.0001925.g002
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viability assay (Figure 2A). Cholesterol depletion following
treatment with 1 mM MbCD was confirmed on the basis of a
dramatic reduction in the intensity of filipin III binding in both
CX+ and CX2 tumor sublines (Figure 2B). Treatment of CX+
tumor cells with 1 and 10 mM MbCD resulted in a significant
reduction in the mean fluorescence intensity (mfi) of Hsp70
expression on CX+ cells (P = 0.006; Figure 2C); whereas no
change in expression was detected on CX2 tumor cells which
express low levels of Hsp70 membrane expression (data not
shown). Similar results were obtained with Colo+/Colo2 tumor
sublines (data not shown). Taken together, these findings suggest
that Hsp70 might be associated with CRMs in the plasma
membrane of tumor cells.
Globotriaosylceramide (Gb3) is Increased in Hsp70
Membrane-Positive Tumor Cells and Co-Localizes with
Hsp70
A comparative analysis of different glycosphingolipids which are
components of CRMs (ceramide, GM1) in Hsp70 membrane-
positive and -negative tumor sublines revealed that the level of
globotriaosylceramide (Gb3/CD77) in CX+ and Colo+ tumor
sublines is significantly greater that that in CX2 and Colo2
tumor sublines (Figure 3). In contrast, levels of lactosylceramide
(LacCer/CDw17), galactosylceramide (GalCer/MAB 342), and
ceramide (Cer/MID 15B4) were low, and were similar. Although
levels of the glycosphingolipid component dodecasaccharideser-
amide (DoCer/CD65s) in the CX+/CX2 tumor subline system
were 5-fold higher than in the Colo+/Colo2 tumor subline
system, no differences were detectable between the Hsp70
membrane-positive and -negative counterparts (data not shown).
Therefore, DoCer was also excluded as a potential interaction
candidate for membrane Hsp70 interactions.
A merge of the staining images (Hsp70-FITC in green and Gb3
in red, CD77 plus Cy3-conjugated secondary antibody) of cell
lines which exhibit differential Gb3 expression, indicated that
these moieties co-localize in the plasma membrane of CX+, but
not CX2 tumor sublines (Figure 4A). Similar data were obtained
using fibroblasts derived from Fabry patients (Figure 4B). Fabry
disease is a rare X-linked hereditary lipid storage disorder in which
the deficiency in the enzyme galactosidase A causes a drastic
increase in Gb3 levels. The Burkitt’s lymphoma cell line Daudi is
extremely positive for Gb3, and Hsp70 and Gb3 also co-localize
on the membranes of these cells (Figure 4C).
Furthermore, incubation of Hsp70 membrane-positive CX+
tumor cells with a sublethal dose of 1-Phenyl-2-Hexadecanoyl
Amino-3-Morpholino-1-Propanol (PPMP1), which eliminates
ceramide-based glycosphingolipids including Gb3 from the plasma
membrane, for 3 and 6 days also resulted in a depletion of Hsp70
from the tumor cell surface (Table 3). These findings further
support the hypothesis that Gb3 serves as an interaction partner
Figure 3. Globotriaosylceramide content is significantly higher
in Hsp70 membrane-positive tumor sublines compared to their
negative counterparts. Comparative analysis of the cell surface
density of glycosphingolipids such as Gb3 (globotriaosylceramide, CD77
Ab), LacCer (lactosylceramide, CDw17 Ab), DoCer (dodecasaccharide-
ceramide, CD65s Ab, data not shown), GalCer (galactosylceramide, MAB
342 Ab), Cer (ceramide, MID15B4 Ab), and GM1 (Cholera Toxin subunit
B) in CX+/CX2 and Colo+/Colo2 tumor sublines. *Indicates values for
Hsp70 membrane-positive (CX+, Colo+) and the corresponding Hsp70
membrane-negative (CX2, Colo2) tumor subline that are significantly
different (P,0.03).
doi:10.1371/journal.pone.0001925.g003
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for Hsp70 in CRMs on the plasma membrane of tumor cells and
Fabry fibroblasts.
Globotriaosylceramide (Gb3) is a Prerequisite for an
Interaction of Hsp70 with Artificial Raft-Like Liposomes
To further characterize the interaction of Hsp70 with Gb3 in
CRMs we performed protein binding studies. Incubation of Gb3-
negative (K562) and Gb3-positive (Daudi) cells with different
concentrations (6, 12, 24 mg/ml) of Hsp70-FITC revealed a
significantly higher binding of Hsp70-FITC to Daudi cells
compared to K562 cells at concentrations of 12 and 24 mg/ml
(Figure 5A). In contrast, BSA-FITC which was used as a control
protein did not bind to Gb3-negative or –positive cells at identical
concentrations (Figure 5B). Similar results were seen with CX+
and CX2 tumor sublines (data not shown). Blocking studies
indicated that the binding of Hsp70-FITC (60 mg/ml) to Daudi
cells could be completely inhibited by the Gb3 (CD77)-specific
mAb, but not by a control antibody specific for ceramide
(MID15B4). These data are in line with the hypothesis that Gb3
serves as an interaction partner for Hsp70 on the cell surface of
tumor cells. To further prove this proposition, we performed
vesicle copellation assays using physiologically relevant lipid
mixtures, including 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (PC)/brain sphingomyelin (SM)/cholesterol (Chol) (PC/
SM/Chol, 17/50/33), PC/SM/Chol/brain cerebroside sulfatide
(CerSul) (17/45/33/5), PC/SM/Chol/galactosylceramide (Gal-
Cer) (17/45/33/5), and PC/SM/Chol/Gb3 (17/45/33/5). A
significant and reproducible binding of Hsp70 to unilamellar
glycosphingolipid vesicles containing Gb3 was observed (Figure 6).
Although a weak interaction of Hsp70 with PC/SM/Chol/
GalCer (17/45/33/5) vesicles was also apparent, these studies
further define the lipid composition which enables Hsp70 to
interact with the plasma membrane of tumor cells and strengthen
the concept that Gb3 plays an important role in this interaction
process.
Discussion
Heat shock proteins with a molecular weight of approximately
70 kDa are located in most subcellular compartments and in these
they fulfill chaperoning tasks including the folding of newly
Table 3. Flow cytometric analysis of viable, 7-AAD- and
Annexin-V-negative CX+ tumor cells either untreated (Ctrl) or
after treatment with a sublethal dose of 1 phenyl-2-
hexadecanoyl amino-3-morpholino-1-propanol (PPMP1,
25 mM) for 3 or 6 days.
Density of Hsp70 membrane-positivity (mfi6SE)a
Ctrl PPMP1 (d3) PPMP1 (d6)
CX+ 16.5362.7 11.161.5 8.4666.6
Data are displayed as the mean fluorescence intensity of Hsp70 positive
cells6SE from at least 3 independent experiments.
ameans significantly different from control (P,0.05).
doi:10.1371/journal.pone.0001925.t003
Figure 4. Bright field and fluorescence microscopic analysis of CX+ and CX2 tumor sublines (A), Fabry fibroblasts (B), and Daudi
Burkitt’s lymphoma cells (C). Cells were stained either with a relevant isotype-matched control antibody (isotype) or with an Hsp70 (cmHsp70.1-
FITC, green) or Gb3 (CD77 plus Cy3-conjugated secondary antibody, red) specific antibody. The co-localization of Hsp70 and Gb3 is visualized in
yellow as a merge of red and green in the lowest panel. Scale bar marks 20 mm. In comparison to CX+ and Fabry cells, the density of Gb3 on the cell
membrane of Daudi cells is markedly increased, as indicated by a high mean fluorescence intensity of the CD77 staining. A double stain of Hsp70-
FITC and Gb3-Cy3 indicates co-localization of both markers on the cell surface (lower right graph). Similar findings were obtained in experiments
using the Colo+/Colo2 tumor sublines (data not shown). On the right hand panel of Figure 4C, representative flow cytometric profiles of Daudi cells
are shown; the upper graph represents the double staining pattern of the isotype-matched antibodies IgM-PE and IgG1-FITC; the graphs below show
single staining of Daudi cells with Hsp70-FITC (second graph) and CD77-PE (third graph). The fourth graph represents the double-staining pattern of
Daudi cells using Hsp70-FITC and CD77-PE antibodies.
doi:10.1371/journal.pone.0001925.g004
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synthesized polypeptides and their transport across membranes
[1,2]. Although lacking a classical consensual transmembrane
sequence, Hsp70, the major stress-inducible member of the
HSP70 family, has also been found to be present on the plasma
membrane [3,4,19] and in the extracellular milieu of cells with an
intact membrane [20–22]. Membrane localization of HSPs
appears to be restricted to transformed [3,4] and virally infected
cells [23], whereas in normal cells, except spermatogenic cells,
Hsp70 is strictly localized within the cell. The presence of Hsp70
proteins in the supernatants of viable tumor cells [9,24,25] is
currently explained by an alternative lysosomal/endosomal
pathway, which does not involve the classical ER Golgi
compartment [26]. These findings concur with those from Asea
and colleagues who demonstrated that drugs which perturb ER
Golgi transport, including monensin and brefeldin A, do not
influence the release of Hsp70 [27].
The export of Hsp70 requires an interaction of the cytosolic
protein with components of the plasma membrane. Given that
high salt and major changes in pH fail to eliminate Hsp70 from
the plasma membrane of tumor cells (unpublished observations),
an electrostatically-driven binding of Hsp70 to protein-based
membrane components appears to be unlikely. Rather, it is likely
that Hsp70 interacts with fatty acids of the plasma membrane, as
has been proposed by Hightower and Guidon in 1989 [7].
Figure 5. Binding of Hsp70-FITC, and BSA-FITC to viable Gb3
membrane-negative K562 and Gb3 membrane-positive Daudi
cells. (A) Significant binding of Hsp70-FITC was observed to Daudi cells
at a concentration of 12 mg/ml and 24 mg/ml. (B) BSA-FITC did neither
bind to K562 nor to Daudi cells, at any of the tested concentrations. (C)
Specific blocking of Hsp70-FITC binding by anti-Gb3 monoclonal
antibody CD77. Daudi cells were kept either untreated or incubated
with anti-Gb3 (CD77), or anti-ceramide (MID15B4) antibodies (5 mg/ml)
for 30 min on ice prior to incubation with Hsp70-FITC (60 mg/ml,
30 min on ice) and analysis by flow cytometry.
doi:10.1371/journal.pone.0001925.g005
Figure 6. Hsp70 predominantly interacts with artificial raft
liposomes containing Gb3. Quantification of the amount of
recombinant Hsp70 protein associated with unilamellar raft-like
liposomal pellet fraction consisting of 1-palmitoyl-2-oleoyl-sn-glycero-
3-phosphocholine (PC)/brain sphingomyelin (SM)/cholesterol (Chol),
(PC/SM/Chol, 17/50/33); 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (PC)/brain sphingomyelin (SM)/cholesterol (Chol)/brain cere-
broside sulfatide (CerSul) (PC/SM/Chol/CerSul, 17/45/33/5); 1-palmi-
toyl-2-oleoyl-sn-glycero-3-phosphocholine (PC)/brain sphingomyelin
(SM)/cholesterol (Chol)/galactocerebroside (GalCer) (PC/SM/Chol/Gal-
Cer, 17/45/33/5); and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (PC)/brain sphingomyelin (SM)/cholesterol (Chol)/globotriasoylcer-
amide (Gb3) (PC/SM/Chol/Gb3, 17/45/33/5). Data are the total
amount of Hsp70 (ng) in the pellet fraction containing liposomes and
are means (6SE) of 3 to 5 independent experiments.
doi:10.1371/journal.pone.0001925.g006
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However, the molecular nature of the interacting lipid component
was not elucidated at that time.
Previous studies have shown that members of the HSP70 family
preferentially interact with artificial liposomes in the presence of
phosphatidylserine (PS) [28,29]. If PS serves as the natural binding
partner for Hsp70 in vivo, then a higher PS content would be
expected in Hsp70 membrane-positive tumor sublines. The
presence of PS at the outer membrane leaflet, as determined by
a specific cell surface staining using the Ca2+-dependent
phospholipid binding protein Annexin-V [30] serves as an early
marker for apoptotic cell death [31]. Since we found here that
Hsp70 membrane-positive tumor sublines do not bind Annexin-V-
FITC and since cell viability, plating efficiency, and doubling-time
was comparable in Hsp70 membrane-positive and -negative
tumor sublines, it appears unlikely that PS serves as the interacting
partner for Hsp70 in the plasma membrane of the cells used in the
current study.
Many reports show that Hsp70 is located in CRMs [8–10],
which are defined as regions within the plasma membrane that are
enriched in cholesterol, glycosphingolipids, glycosylphosphatidyli-
nositol-anchored proteins and some other acetylated proteins [32].
CRMs, also termed as lipid rafts [33], serve as assembly and
sorting platforms for signal transduction complexes, increase cell
interactions and thus enhance inter-cellular crosstalk. These
functions might explain the presence of stress proteins with
chaperoning function in CRMs. In line with previous findings
from others, cholesterol depletion with MbCD results in a loss of
Hsp70 from the plasma membrane of tumor cells.
A comparative lipidomic analysis of the content of CRM-
residing glycosphingolipids revealed significantly greater amounts
of globotriaosylceramide Gb3 [34] in Hsp70 membrane-positive
tumor sublines, as compared to their Hsp70 membrane-negative
counterparts. In contrast, the content of other ceramide-derived
glycosphingolipids such as lactosylceramide, dodecasaccharide-
ceramide, galactosylcereamide and ceramide in Hsp70 mem-
brane-positive and -negative tumor sublines were similar. Gb3 is
known to serve as a receptor for Shiga toxin, an enterotoxin
produced by Shigella dysenteria and enterohemorrhagic Escherichia
coli, and is frequently found on germinal centre B cells and on
tumor cells [35–37], but rarely on normal cells. The selective
enrichment of Gb3 in the plasma membrane of Hsp70-positive
tumor sublines led us to the hypothesis that Gb3 might act as
an interaction partner for Hsp70 in the plasma membrane. In
line with these results we could further show that Hsp70 was
eliminated from the plasma membrane concomitant with a loss of
ceramide-based glycosphingolipids, including Gb3, following
treatment with PPMP1. Previous work of Lingwood et al has
demonstrated that Hsp70 binds to 39-sulfogalactolipids via the
ATPase domain [38]. Based on binding patterns of Hsp70
antibodies that detect different epitopes in the ATPase and the C-
terminal substrate binding domain, the orientation of Hsp70 in
Gb3 containing CRMs appears to be identical (unpublished
observation). Together with the finding that Hsp70 interacts
only with artificial raft-like liposomes containing Gb3, we
conclude that Gb3 has an important role in the interaction of
Hsp70 with the plasma membranes of Hsp70 membrane-positive
tumors.
Materials and Methods
Chemicals and Reagents
All chemicals and reagents were obtained from Sigma-Aldrich
or from Carl Roth unless stated otherwise.
Cells and Cell Culture
Established human colon (CX2; Tumorzellbank, DKFZ,
Heidelberg, Germany) and pancreas (Colo357; Centre for Applied
Microbiology and Research, Salisbury, UK) carcinoma cells were
separated into the sublines CX+/CX2 and Colo+/Colo2 by
fluorescence activated cell sorting using the FITC-conjugated
Hsp70-specific mAb cmHsp70.1 (multimmune GmbH, Munich,
Germany). CX+ (87%) and Colo+ (73%) tumor sublines contain
consistently high proportions of Hsp70 membrane-positive cells,
and CX2 (23%) and Colo2 (34%) contain consistently low
proportions of Hsp70 membrane-positive cells [16,17]. The
human cervix carcinoma cell line HeLa was stably transfected
with an expression vector harboring mouse Bag-4 cDNA (pcDNA-
SODD, access code Q8CI61), or with the corresponding control
vector, neo. DNA (8 mg) was electroporated into 56106 cells using
a BioRad gene pulser (750 V, 25 mF, 200 Ohm, 0.4 cm cuvettes)
and cells were selected in medium containing G418 (0.3 mg/ml,
Calbiochem, San Diego, USA). Bag-4 stably transfected clones
overexpressing Hsp70 on their cell surface were selected and
cultured as described above [18]. Plating efficiency, doubling time
(20 h), and protein content (indicated in Figure 2A) in membrane
Hsp70 low- and high-expressing tumor sublines were similar.
The mycoplasma-free human erythroleukemic (K562) and
Burkitt’s lymphoma (Daudi) tumor cell lines and primary
fibroblasts derived from a patient with Fabry disease having a
high Gb3 content were maintained in exponential growth by
regular passages (typically every 3 days) in RPMI 1640 supple-
mented with 5% v/v heat-inactivated fetal calf serum (FCS),
50 IU/ml penicillin, 50 mg/ml streptomycin, 2 mM L-glutamine,
and 1 mM sodium pyruvate (Life Technologies, Eggenstein,
Germany).
Biotinylation of Membrane Proteins, SDS-PAGE and
Western Blot Analysis
Following three washing steps in ice cold, serum-free phosphate
buffered saline (PBS, pH 7.5), viable tumor cells (.97%) were
resuspended in PBS at a density of 16106 cells/ml and incubated
with biotinylation reagent (EZ-Link sulfo-NHS-LC-biotin, 1 mg/
ml, Pierce) under gentle rotation. After 30 min, the biotinylation
process was terminated by the addition of Tris-HCl (pH 7.5) to a
final concentration of 50 mM. After 3 washing steps in PBS, cells
were solubilized in lysis buffer (1% v/v Triton X-100) containing
protease inhibitors and completely disrupted by dounce homog-
enization (20 strokes). Solubilized biotinylated membrane proteins
were centrifuged (14,000 rpm for 30 min at 4uC) and supernatants
were purified twice on ImmunoPure (Pierce) avidin columns
according to the manufacturer’s recommended protocol. Biotiny-
lated membrane proteins were eluted from the column with 5 mM
biotin in PBS containing 1% v/v Triton-X, concentrated on
Centricon YM-3 columns (Millipore) and subjected to SDS-
PAGE.
For SDS-PAGE, solutions of biotinylated membrane proteins
and whole cell membranes were denatured in sample buffer
(25 mM Tris hydrochloride (pH 6.8), 2% w/v SDS, 10% v/v
glycerol, 10% v/v dithiothreitol, 0.2% w/v bromophenol blue)
and heated for 10 min at 95uC. Proteins were separated by 10%
SDS-PAGE under reducing conditions [39], blotted onto
nitrocellulose membranes [40] and stained either with Ponceau
S solution or primary mAbs directed against Hsp70 (cmHsp70.1,
multimmune GmbH or SPA-810, Assay Designs, Ann Arbor,
USA), ganglioside GM1 or tubulin. Biotinylated proteins and
bound mAbs were visualized using a horseradish peroxidase
complex or peroxidase-conjugated secondary antibodies (Dako,
Hamburg, Germany) and chemiluminescence (ECL, Amersham
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Biosciences, Chalfont St. Giles, UK). The amount of protein in the
samples was quantified by densitometry and compared to the
signals generated by tubulin staining and corresponding recom-
binant Hsp70 protein (NSP-555, Assay Designs) which was run in
parallel (100 ng per lane).
Analysis of Lipid Composition
Plasma membranes and CRMs were isolated as mentioned
above and analyzed by mass spectrometry, as described elsewhere.
Briefly, lipids were quantified by electrospray ionization tandem
mass spectrometry (ESI-MS/MS) in positive ion mode as
described previously [41–43]. Samples were quantified by direct
flow injection analysis using the analytical setup described by
Liebisch et al. [42,43]. A Precursor Ion Scan of m/z 184 specific
for phosphocholine containing lipids was used for phosphatidyl-
choline (PC) and sphingomyelin (SM) [42]. Neutral Loss Scans of
m/z 141 and m/z 185 were used for phosphatidylethanolamine
(PE) and phosphatidylserine (PS) respectively [41]. Ceramide was
analyzed using a similar approach to that described previously
[44] using N-heptanoyl-sphingosine as an internal standard. Free
cholesterol (FC) and cholesteryl ester (CE) were quantified using a
fragment ion of m/z 369 after selective derivatization of FC using
acetyl chloride [42]. Correction of isotopic overlap of lipid species
as well as data analysis by self programmed Excel Macros was
performed for all lipid classes according to previously described
principles [43].
Methyl-Beta Cyclodextrin (MbCD) and 1 Phenyl-2-
Hexadecanoyl Amino-3-Morpholino-1-Propanol (PPMP1)
Treatment
Tumor cells were incubated with 1 mM and 10 mM of the raft-
disrupting agents MbCD, for 1 h at 37uC (Sigma-Aldrich), washed
and then resuspended in fresh medium. Tumor cells were also
treated with a sublethal dose of PPMP1 (25 mM) for 3 or 6 days in
order to eliminate ceramide-based glycosphingolipids, including
Gb3, from the plasma membrane.
Flow Cytometry
Following a washing step, untreated and cholesterol-depleted
viable tumor cells were counted and 0.16106 cells were incubated
with an FITC-conjugated cmHsp70.1 mAb, and antibodies
directed against Gb3 (CD77, BD Biosciences, Heidelberg,
Germany; [Gal(a1–4)Gal(b1–4)Glc ceramide]), LacCer (lactosyl-
ceramide, CDw17, BD Biosciences), DoCer (dodecasaccharide-
ceramide, CD65s, BD), GalCer (galactosylceramide, MAB 342,
Chemicon International, Temecula, USA), Cer (ceramide,
MID15B4, Axxora Life Sciences, San Diego, USA), a secondary
PE-conjugated antibody (Dako) or an FITC-conjugated IgG1
isotype-matched control (Cymbus Biotechnology, Eastleigh, UK),
for 15 min at 4uC. GM1 was visualized by incubating the tumor
cells with 5 ml of the Alexa Fluor 555-conjugated cholera toxin
subunit B (dilution 1:10, Molecular Probes Europe BV, Leiden,
Netherlands) for 30 min at room temperature. Cells were washed
and resuspended in PBS containing 10% v/v heat-inactivated
FCS. Only viable, 7-amino-actinomycin D negative (7-AAD, BD
Biosciences) cells were analyzed on a FACSCaliburTM flow
cytometer (BD Biosciences). To determine the PS content in the
outer leaflet, cells were incubated with 5 ml Annexin-V-FITC in
150 ml Ca2+ containing Annexin-V-binding buffer (BD Pharmin-
gen) for 15 min at room temperature in the dark. Mean
fluorescence intensities (mfi) were determined by subtracting the
value obtained using the isotype-matched control immunoglobulin
from the experimental value.
Immunostaining
Tumor cells were stained either with 2 ml of the FITC-
conjugated Hsp70-specific mAb cmHsp70.1 (0.5 mg/ml), 5 ml of
the Alexa Fluor 555-conjugated cholera toxin B subunit (dilution
1:10, Molecular Probes Europe BV), Gb3/CD77 antibody (BD
Biosciences) and a secondary Cy3-conjugated antibody (Dako),
filipin III (50 mg/ml; Sigma-Aldrich) which binds cholesterol
within the plasma membrane, or with the relevant isotype-
matched control antibodies for 30 min in the dark. Cells were then
transferred onto glass slides in Fluorescent Mounting Medium
(Dako) and cytospin preparations were made. Slides were analyzed
by transmission and fluorescence microscopy using a Leica SP5
confocal microscope equipped with 6100 (planar) and 663
(apochromatic) oil-immersion objective (Acousto Optical Beam
Splitter system). Pictures of specifically stained cells and overlays
were taken and editing was performed using MetamorphH
software (Universal Imaging, Downingtown, USA). The location
of cholesterol is visualized in blue (filipin III), that of Hsp70 in
green (FITC), and that of Gb3 in red (Cy3). An overlay technique
revealed the co-localization of Hsp70 and Gb3 in yellow.
Protein Binding Assay
Gb3-negative (K562) and Gb3-positive (Daudi) tumor cell lines
were incubated either with Hsp70-FITC or BSA-FITC at different
concentrations (6–24 mg/ml) for 30 min on ice. After 2 washes in
PBS cells were analyzed by flow cytometry, as described above.
For blocking assays, the tumor cell lines (16106) were incubated
either with 5 mg/ml of unlabeled Gb3 (CD77) or ceramide
(MID15B4) antibodies for 20 min on ice, followed by FITC-
Hsp70 (60 mg/ml).
Vesicle Copellation Assay
Unilamellar vesicles with a nominal diameter of 200 nm were
prepared according to the extrusion method. Briefly, mixed lipid
films were prepared under a stream of nitrogen followed by 3 h
under vacuum and stored at 4uC. Multilamellar vesicles (MLVs)
were formed by first swelling the lipid films in buffer solution
(50 mM TRIS/HCl, pH 7.4) for 30 min followed by vortexing
three times for 30 sec every 5 min. Large unilamellar vesicles
(LUVs) were produced form MLVs by pressing them through a
polycarbonate membrane with 200 nm pore diameter using a
mini extruder (LipoFast, Avestin, Canada). LUVs (1 mg/ml) were
incubated with Hsp70 (1 mg/ml) for 30 min at room temperature
in 1 mM Bis/Tris buffer, pH 7.4 and then centrifugated at 4uC
(200,0006 g). Pelleted fractions were subjected to SDS-PAGE
analysis.
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